ArticleHealth services insights2026
Telemedicine Use Amongst US Children and Young Adults With Autism: Utilization, Costs and Common Conditions.
Article in Health services insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The management of autism and other comorbidities among children and young adults places a substantial economic and logistical burden on families. Telemedicine offers potential benefits for children and young adults with autism by improving access to care, reducing costs, and supporting families in managing ongoing treatment needs, all highlighted during the COVID-19 pandemic. While telemedicine has shown positive benefits in neurotypical pediatric populations, limited evidence supports and describes the use of telemedicine for children with autism. Objective: This study examined children and young adults with autism and assessed the association between telemedicine services and annual combined out-of-pocket (OOP) medical costs among children and young adults with autism. Design: Cross-sectional data from the U.S. nationally representative Medical Expenditure Panel Survey (MEPS) were analyzed. Independent variables included demographics, medical conditions, utilization patterns, and healthcare expenditures. A weighted log-linear regression model estimated combined medical OOP costs, and a binary weighted logistic regression examined factors associated with telemedicine use. Data: The study cohort included 189 children and young adults with autism aged 1-21 years from 2020 to 2023. Results: Among them, 62 (32.8%) used telemedicine. By 2023, telemedicine utilization among children and young adults with exceeded those who did not use telemedicine. Telemedicine utilization did not have a significant effect on OOP costs (EXP(β) = 1.30, Conclusion: Telemedicine use was not significantly associated with combined OOP medical costs among children and young adults with autism. However, differences were observed in telemedicine use and OOP costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.